Basics Kymera Therapeutics, Inc. IPO Date: August 21, 2020 Sector: Healthcare Industry: Biotech Market Cap: $4.17B Activated in VL: True Average Daily Range Avg Daily Range: $1.20 | 3.18% Avg Daily Range (30 D): $1.57 | 2.86% Avg Daily Range (90 D): $1.01 | 2.08% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): .68M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 55 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 2,286 Avg Inst. Trade: $2.46M Avg Inst. Trade (30 D): $3.57M Avg Inst. Trade (90 D): $3.28M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.3M Avg Closing Trade (30 D): $7.16M Avg Closing Trade (90 D): $5.61M Avg Closing Volume: 92.88K     News Sep 17, 2025 @ 11:00 AM Kymera Therapeutics Announces Late-Breaking Oral P... Source: Kymera Therapeutics Sep 3, 2025 @ 11:00 AM Kymera Therapeutics Appoints Brian Adams as Chief ... Source: Brian Adams Aug 13, 2025 @ 12:00 PM Hatteras Venture Partners Raises Over $200 Million... Source: Clay Thorp And John Crumpler Aug 11, 2025 @ 11:28 AM Kymera Revenue Drops 55 Percent in Q2 Source: Jesterai Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.48 $-.95 $-.82 Diluted EPS $-3.48 $-.95 $-.82 Revenue $ 44.71M $ 11.48M $ 22.1M Gross Profit $ M $ M $ M Net Income / Loss $ -275.43M $ -76.61M $ -65.58M Operating Income / Loss $ -311.86M $ -84.56M $ -74.43M Cost of Revenue $ 44.71M $ 11.48M $ 22.1M Net Cash Flow $ 268.18M $ 245.86M $ -30.28M PE Ratio